However, in the age groups divided into below or above median age in each disease, the significance of LXRA in RA patients who were not treated by bDMARDs was missing (Supplementary Table S3), which illustrated the accuracy of age classification in Table 3. This evidence concerns the gene NR1H3 and rheumatoid arthritis.